Skip to main content
Equibles
IMMX logo

IMMX · Immix Biopharma, Inc. · Held by Funds

Track IMMX — free

Use IMMX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMMX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.05 -0.01 (-0.12%) At close · Oct 27
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 7, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company is unable to entirely fund these efforts with its current financial resources. If adequate funds are unavailable on a timely basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more of its research or development programs which may materially and adversely affect its business, financial condition and operations.”
View the 10-Q filed Aug 7, 2026
Market Cap
$576.61M
Shares
71.54M
Volume · Oct 27 1.15M Avg daily vol (3M) 1.54M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of IMMX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 9.82% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.24% 885,524
Index ETFs 8.59% 6,142,752
Active ETFs 0.00% 64
Active funds 8.54% 6,110,923
Unclassified 0.01% 9,946
All registered funds 18.38% 13,149,209
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding IMMX

85 fund positions
Fund Balance Value % of Fund Open
Eventide Healthcare & Life Sciences Fund 3,891,019 $40,116,406 2.24%
State Street(R) SPDR(R) S&P(R) Biotech ETF 2,104,035 $21,692,601 0.20%
VANGUARD TOTAL STOCK MARKET INDEX FUND 1,780,495 $18,356,903 0.00%
T. Rowe Price Health Sciences Fund, Inc. 1,326,256 $13,673,699 0.11%
iShares Russell 2000 ETF 1,067,981 $11,010,884 0.01%
VANGUARD EXTENDED MARKET INDEX FUND 681,413 $7,025,368 0.01%
Columbia Small Cap Value Discovery Fund 483,630 $4,023,802 0.16%
Fidelity Extended Market Index Fund 286,567 $4,020,535 0.01%
iShares Russell 2000 Growth ETF 370,703 $3,821,948 0.02%
Fidelity Small Cap Index Fund 449,259 $3,737,835 0.01%
Franklin Biotechnology Discovery Fund 357,034 $2,970,523 0.26%
Fidelity Total Market Index Fund 109,352 $1,534,209 0.00%
Timber Point Global Allocations Fund 140,000 $1,443,400 4.51%
iShares Micro-Cap ETF 138,125 $1,424,069 0.09%
Fidelity Series Total Market Index Fund 92,004 $1,290,816 0.00%
T. Rowe Price Health Sciences Portfolio 82,613 $851,740 0.11%
Schwab Small-Cap Index Fund 99,794 $830,286 0.01%
Ultra-Small Company Fund 80,000 $824,800 0.83%
Master Small Cap Index Series 76,786 $791,664 0.01%
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF 43,843 $615,117 0.06%
Direxion Daily S&P Biotech Bull 3X Shares 71,495 $594,838 0.12%
EQ/2000 Managed Volatility Portfolio 44,723 $461,094 0.01%
Nuveen Small Cap Blend Index Fund 54,609 $454,347 0.01%
Fidelity Small Cap Growth Index Fund 38,484 $396,770 0.03%
Schwab Total Stock Market Index Fund 47,380 $394,202 0.00%
Blackstone Alternative Multi-Strategy Fund 33,534 $345,736 0.01%
Fidelity Nasdaq Composite Index Fund 22,933 $321,750 0.00%
Columbia Variable Portfolio - Small Company Growth Fund 30,390 $313,321 0.12%
LVIP State Street Small-Cap Index Fund 29,800 $307,238 0.01%
Virtus Biotech Clinical Trials Etf 36,782 $306,026 0.66%
Nuveen Equity Index Fund 36,034 $299,803 0.00%
Health Sciences Trust 27,992 $288,598 0.11%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND 22,835 $235,429 0.00%
VANGUARD BALANCED INDEX FUND 22,585 $232,851 0.00%
Small Cap Index Fund 21,124 $217,788 0.01%
EQ/T.Rowe Price Health Sciences Portfolio 19,704 $203,148 0.12%
EQ/AB Small Cap Growth Portfolio 16,780 $173,002 0.01%
EQ/Small Company Index Portfolio 16,780 $173,002 0.01%
BIOTECHNOLOGY ULTRASECTOR PROFUND 20,062 $166,916 0.14%
Global X Russell 2000 ETF 19,540 $162,573 0.01%
ATM Small Cap Managed Volatility Portfolio 14,902 $153,640 0.01%
Small Cap Core Fund 14,396 $148,423 0.04%
STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO 14,300 $147,433 0.00%
MetLife Russell 2000 Index Portfolio 14,131 $145,691 0.01%
Small-Cap Index Portfolio 11,790 $121,555 0.01%
PROFUND VP BIOTECHNOLOGY 9,329 $96,182 0.20%
1290 VT Micro Cap Portfolio 9,203 $94,883 0.04%
Multi-Manager U.S. Small Cap Equity Fund 10,622 $94,854 0.03%
NVIT Small Cap Index Fund 9,166 $94,501 0.01%
Small Cap Index Trust 8,523 $87,872 0.01%
Showing 1–50 of 85 positions
Key facts CIK 1873835 CUSIP 45258H106 13F (30d) 12 filings 12 filers Visit website Investor relations